# Impact of Therapeutic Patient Education on the Toxicity of Immune Checkpoint Inhibitors in Oncology

> **NCT03948724** · NA · COMPLETED · sponsor: **Institut Cancerologie de l'Ouest** · enrollment: 411 (actual)

## Conditions studied

- Therapeutic Patient Education
- Immune Checkpoint Inhibitors
- Melanoma
- Advanced Non-small Cell Lung Cancer
- Renal Cell Carcinoma
- Head and Neck Cancer
- Immune-related Adverse Event

## Interventions

- **BEHAVIORAL:** Therapeutic education program
- **BEHAVIORAL:** Usual Information

## Key facts

- **NCT ID:** NCT03948724
- **Lead sponsor:** Institut Cancerologie de l'Ouest
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-12-11
- **Primary completion:** 2023-08-04
- **Final completion:** 2024-08-22
- **Target enrollment:** 411 (ACTUAL)
- **Last updated:** 2025-08-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03948724

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03948724, "Impact of Therapeutic Patient Education on the Toxicity of Immune Checkpoint Inhibitors in Oncology". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT03948724. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*